ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)


Volume 17, 9 Issues, 2017


Download PDF Flyer

http://www.currentcancerdrugtargets.com/


Current Cancer Drug Targets

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Ruiwen Zhang


Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.992
5 - Year: 3.412
Browse Contents
Select Volume:


Select Issue:


Select Article:


Abstracted/Indexed in




Endorsement(s)

"This journal fills an important need in providing reviews, covering the moving area of new cancer drug targets."

Paul Workman
CRC Centre for Cancer Therapeutics, England

Forthcoming Special Issue(s)

CANCER EPIGENETICS


Guest Editor(s): Aamir Ahmad
Tentative Publication Date: November, 2017
Submit Abstract via Email Download Description
Published Special Issue(s)

CANCER BIOMARKERS FROM BENCH TO BEDSIDE


Guest Editor(s): BALÁZS GYŐRFFY
Download Description
Authors' Comments
"I would like to express my sincere thanks for the services by Bentham Science.
I'm really happy with my submission in your Journal and hope that I will able to continue submitting manuscripts to your journal"

Saeed Samarghandian
(Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran)



Current Cancer Drug Targets

,

Volume 17

-

Number 9



Review Article

Stem Cell Transplantation in Multiple Myeloma

, 17(9): 769 - 781

Massimo Offidani, Silvia Gentili, Francesca Gay, Elena Aghemo, Laura Maracci, Laura Corvatta and Antonio Palumbo


DOI: 10.2174/1568009616666160920090236


Abstract PubMed Reprints Eprints Permissions




Review Article

Multiple Myeloma and the Immune Microenvironment

, 17(9): 806 - 818

Yawara Kawano, Aldo. M. Roccaro, Irene M. Ghobrial and Jamil Azzi


DOI: 10.2174/1568009617666170214102301


Abstract PubMed Reprints Eprints Permissions




Review Article

Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment

, 17(9): 819 - 838

Cirino Botta, Maria Cuce, Daniele Caracciolo, Lucia Fiorillo, Pierosandro Tagliaferri and Pierfrancesco Tassone


DOI: 10.2174/1568009617666170330154756


Abstract PubMed Reprints Eprints Permissions




Review Article

Ponatinib: A Review of Efficacy and Safety


Fulvio Massaro, Matteo Molica and Massimo Breccia*


View Abstract View on PubMed



Neoisoliquiritigenin Inhibits Tumor Progression by Targeting GRP78-β- catenin Signaling in Breast Cancer


Hailin Tang*, Fu Peng, Xiaojia Huang, Xinhua Xie, Bo Chen, Jiangang Shen, Fei Gao, Jieshu You, Xiaoming Xie and Jianping Chen


View Abstract



Evaluation of Anti-cancer Activity of Stilbene and Methoxydibenzo[b,f] oxepin Derivatives


Damian Garbicz , Damian Mielecki , Michał Wrzesiński , Tomasz Pilżys, Michał Marcinkowski , Jan Piwowarski , Janusz Dębski, Ewelina Palak, Przemysław Szczeciński, Hanna Krawczyk and Elżbieta Grzesiuk*


View Abstract View on PubMed



AR copy number and AR signaling-directed therapies in castration-resistant prostate cancer


Samanta Salvi*, Vincenza Conteduca, Cristian Lolli, Sara Testoni, Valentina Casadio, Andrea Zaccheroni, Lorena Rossi, Salvatore Luca Burgio, Cecilia Menna, Giuseppe Schepisi and Ugo De Giorgi


View Abstract



Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling


Xinhua Xie, Xiaojia Huang, Hailin Tang, Feng Ye, Lu Yang, Xiaofang Guo, Zhi Tian, Cheng Peng* and Xiaoming Xie*


View Abstract



Identification of Novel Agents for the Treatment of Brain Metastases of Breast Cancer

, 2017; 17(5): 479 - 485

Vinay K. Venishetty, Werner J. Geldenhuys, Tori B. Terell-Hall, Jessica I.G. Griffith, Gregory R. Sondag, Fayez F. Safadi and Paul R. Lockman*


DOI: 10.2174/1568009617666161121123948
Abstract PubMed Reprints Eprints Permissions



Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy

, 2017; 17(3): 236 - 254

Drew A. Spencer, Brenda M. Auffinger, Jason P. Murphy, Megan E. Muroski, Jian Qiao, Yureve Gorind and Maciej S. Lesniak


DOI: 10.2174/1568009616666161215161924
Abstract PubMed Reprints Eprints Permissions



Does Hypoxic Response Mediate Primary Resistance to Sunitinib in Untreated Locally Advanced Breast Cancer?

, 2017; 17(1): 62 - 73

Sofia Braga, Joana Cardoso, Saudade Andre, Margarida Brito, Pedro Sanchez, Lurdes Orvalho, Lucilia Salgado, Sergio Dias, Jose B. Pereira-Leal and Jose Luis Passos-Coelho


DOI: 10.2174/1568009616666161025114914
Abstract PubMed Reprints Eprints Permissions



Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening

, 2016; 16(9): 818 - 828

Amit Sharma, Nidhi Jyotsana, Courteney K. Lai, Anuhar Chaturvedi, Razif Gabdoulline, Kerstin Görlich, Cecilia Murphy, Jan E. Blanchard, Arnold Ganser, Eric Brown, John A. Hassell, R. Keith Humphries, Michael Morgan and Michael Heuser


DOI: 10.2174/1568009616666160617103301
Abstract PubMed Reprints Eprints Permissions



Deregulation of Apoptosis - Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?

, 2016; 16(8): 652 - 658

Monika Podhorecka, Arkadiusz Macheta, Maria Bozko, Andrzej Bozko, Nisar P. Malek and Przemyslaw Bozko


DOI: 10.2174/1568009616666160427103930
Abstract PubMed Reprints Eprints Permissions



Advertisement

Related Journals




Related eBooks



Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science